COMMUNIQUÉS West-GlobeNewswire

Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
17/04/2026
INBS implements enhanced security architecture to protect test integrity and donor data, strengthening upcoming FDA 510(k) submission NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: [...]
Global Widget Celebrates 10 Years as a Leader in Premium Gummy Manufacturing
17/04/2026
Global Widget, LLC, a leading U.S.-based contract manufacturer specializing in gummy supplements, is celebrating its 10-year anniversary after a decade of rapid growth and operational expansion. Tampa, Florida, April 17 [...]
Omada Health Helps Members on GLP‑1s Lose More Fat, Preserve Muscle Mass, and Improve Mental Health, New Study Finds
17/04/2026
In a 12‑week comparative study, Omada GLP‑1 Care Track members, on average, lost more weight and saw greater improvements in body composition than controls, pointing to increased value for employers and health plans. [...]
Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine
17/04/2026
Company highlights global leadership in GMP ibogaine manufacturing and commitment to ethically sourced supply NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “ [...]
BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting
17/04/2026
Live event to be held on Thursday, April 23, at 2:00 p.m. ET Company focused on advancing launch strategy ahead of November 14 PDUFA target action date NEW HAVEN, Conn., April 17, 2026 (GLOBE NEWSWIRE) -- BioXcel [...]
Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
17/04/2026
– Updated presentation on Cogent’s potent pan-KRAS(ON) inhibitor, CGT1263, showcasing its selectivity profile which could lead to reduction in skin toxicity associated with multi-RAS inhibitors – Updated presentation on [...]
Vistin Pharma ASA: Invitation to Q1 2026 conference call
17/04/2026
Oslo, Norway, 17 April 2026 Vistin Pharma ASA (VISTN) will release its first quarter results on Friday 24th of April 2026. Vistin Pharma will host a conference call for all shareholders and interested parties on the [...]
New Nordic white paper reveals systemic barriers preventing women from reaching leadership roles
17/04/2026
Report outlines 17 targeted actions to address structural barriers hindering leadership progression COPENHAGEN, Denmark and OSLO, Norway and STOCKHOLM, April 17, 2026 (GLOBE NEWSWIRE) -- The Nordic life science sector [...]
Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib
17/04/2026
Data from subset analysis of cabozantinib-pretreated patients support potential to overcome resistance and resensitize tumors to VEGF TKI therapy 44% ORR and 94% DCR in ccRCC patients previously treated with [...]
Immuron Double Digit 3Q Sales Growth
17/04/2026
Sales Highlights (unaudited): Global Q3 sales AUD$1.5 million up 16% on prior comparative period (pcp) YTD Mar 2026 sales AUD$5.7 million up 7% on prior comparative period (pcp) Australia Q3 sales AUD$0.9 million up 15 [...]
CARBIOS présente ses résultats annuels 2025
17/04/2026
Carbios a fortement réduit ses charges opérationnelles au cours de l’année 2025, permettant une réduction de la perte d’exploitation de 7 millions d’euros Carbios dispose d’une trésorerie solide à hauteur de 59 millions [...]
Bioxodes expands Clinical Advisory Board, shares pivotal trial design for BIOX-101 in intracerebral hemorrhage
17/04/2026
Three world-leading key opinion leaders, researchers and clinicians, join Clinical Advisory Board, reinforcing Bioxodes’ global registrational clinical strategy Positive ongoing discussions with regulators on pivotal [...]
Carbios announces fiscal-year 2025 financial results
17/04/2026
Carbios significantly reduced its operating expenses during 2025, resulting in a €7 million reduction in operating loss Carbios has a solid cash position of €59 million as of December 31, 2025, on a Group basis [...]
Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock
17/04/2026
NEW HAVEN, Conn., April 16, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the [...]
OraSure Technologies Appoints John D. Bertrand to its Board of Directors
17/04/2026
Enters into Cooperation Agreement with Altai Capital Board to Seek Shareholder Approval for Declassification at the 2026 Annual Meeting BETHLEHEM, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“ [...]
Kailera Therapeutics Announces Pricing of Initial Public Offering
17/04/2026
WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA) (Kailera), an advanced clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced [...]
New Preclinical Data on STX-1, a First-in-Class Senolytic ADC, To Be Presented at AACR 2026
16/04/2026
PRESS RELEASE New Preclinical Data on STX-1, a First-in-Class Senolytic ADC, To Be Presented at AACR 2026 Presentations highlight therapy-induced senescence as a new therapeutic opportunity and reinforce the potential [...]
Globus Medical Schedules First Quarter Earnings Release and Conference Call
16/04/2026
AUDUBON, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March 31, 2026 after the [...]
Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year
16/04/2026
Sanuwave is pleased to announce preliminary revenues of $9.6 million to $9.7 million for the first quarter ended March 31, 2026, in line with prior guidance for Q1. EDEN PRAIRIE, Minn., April 16, 2026 (GLOBE NEWSWIRE [...]

Pages